| __timestamp | Exelixis, Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 23068000 | 51585000000 |
| Thursday, January 1, 2015 | 33277000 | 48538000000 |
| Friday, January 1, 2016 | 184902000 | 50205000000 |
| Sunday, January 1, 2017 | 437411000 | 51096000000 |
| Monday, January 1, 2018 | 827478000 | 54490000000 |
| Tuesday, January 1, 2019 | 934678000 | 54503000000 |
| Wednesday, January 1, 2020 | 951266000 | 54157000000 |
| Friday, January 1, 2021 | 1382097000 | 55338000000 |
| Saturday, January 1, 2022 | 1553153000 | 55394000000 |
| Sunday, January 1, 2023 | 1757661000 | 58606000000 |
| Monday, January 1, 2024 | 2168701000 | 33879000000 |
Igniting the spark of knowledge
In the world of pharmaceuticals, the battle for supremacy often boils down to financial prowess. Over the past decade, Johnson & Johnson has consistently outperformed Exelixis, Inc. in terms of gross profit. From 2014 to 2023, Johnson & Johnson's gross profit surged by approximately 14%, peaking at $58.6 billion in 2023. In contrast, Exelixis, Inc. experienced a remarkable growth trajectory, with its gross profit skyrocketing by over 7,500%, reaching $1.76 billion in the same year.
While Johnson & Johnson's dominance is evident, Exelixis, Inc.'s rapid growth is noteworthy, reflecting its strategic advancements in the biotech sector. This financial narrative underscores the dynamic nature of the pharmaceutical industry, where established giants and emerging players continuously vie for market leadership.
Gross Profit Comparison: Eli Lilly and Company and Exelixis, Inc. Trends
Novo Nordisk A/S and Johnson & Johnson: A Detailed Gross Profit Analysis
Johnson & Johnson vs Amgen Inc.: A Gross Profit Performance Breakdown
Johnson & Johnson and Regeneron Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Vertex Pharmaceuticals Incorporated and Exelixis, Inc.: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Exelixis, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: BioMarin Pharmaceutical Inc. and Exelixis, Inc. Trends
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs Exelixis, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Lantheus Holdings, Inc.
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis